Evidence map›Paper›PMID 34650556›Full record

ArticleFrontiers in immunology2021

Evolution of Serum Acute-Phase Glycoproteins Assessed by

Ana-Irene Malo, Joaquim Peraire, Ezequiel Ruiz-Mateos, Jenifer Masip, Núria Amigó, José Alcamí, Santiago Moreno, Josefa Girona, Graciano García-Pardo, Rosaura Reig and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Glycoprotein Profile Measured by aLife (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 1 country.

Ana-Irene MaloVascular Medicine and Metabolism Unit, Hospital Universitari Sant Joan, Reus, Spain.
Joaquim PeraireHospital Universitari de Tarragona Joan XXIII, Tarragona, Spain.
Ezequiel Ruiz-MateosUnidad Clínica de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Instituto de Biomedicina de Sevilla-Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain.
Jenifer MasipHospital Universitari de Tarragona Joan XXIII, Tarragona, Spain.
Núria AmigóUniversitat Rovira i Virgili, Tarragona, Spain.
José AlcamíCentro de Investigación Biomédica en Red de Enfermedades Infecciosas, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Santiago MorenoCentro de Investigación Biomédica en Red de Enfermedades Infecciosas, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Josefa GironaUniversitat Rovira i Virgili, Tarragona, Spain.
Graciano García-PardoHospital Universitari de Tarragona Joan XXIII, Tarragona, Spain.
Rosaura ReigHospital Universitari de Tarragona Joan XXIII, Tarragona, Spain.
Francesc VidalHospital Universitari de Tarragona Joan XXIII, Tarragona, Spain.
Antoni CastroVascular Medicine and Metabolism Unit, Hospital Universitari Sant Joan, Reus, Spain.
Lluís MasanaVascular Medicine and Metabolism Unit, Hospital Universitari Sant Joan, Reus, Spain.
Anna RullHospital Universitari de Tarragona Joan XXIII, Tarragona, Spain.
Hospital Universitari Joan XXIII de Tarragona · ESCentro de Investigación Biomédica en Red · ESHospital Universitari Sant Joan de Reus · ESInstituto de Salud Carlos III · ESCentro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas · ESInstituto de Biomedicina de Sevilla · ESUniversidad Rovira i Virgili · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Elite controllers (ECs) are an exceptional group of people living with HIV (PLWH) who maintain undetectable viral loads (VLs) despite not being on antiretroviral therapy (ART). However, this phenotype is heterogeneous, with some of these subjects losing virological control over time. In this longitudinal retrospective study, serum acute-phase glycoprotein profile assessed by proton nuclear magnetic resonance (

Indexed as

GlycomicsHIV Non-ProgressorsProteomeProteomicsProton Magnetic Resonance SpectroscopyAcute-Phase ProteinsAdultBiomarkersFemaleHIVHIV InfectionsHost-Pathogen InteractionsHumansLongitudinal StudiesMaleMiddle AgedAcute-Phase ProteinsBiomarkersProteomeacute-phase glycoproteinselite controllersHIVinflammationproton nuclear magnetic resonance

Identifiers

PMID34650556
PMCPMC8505996
OpenAlexW3204677021

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.